IJCNMH ARCpublishing

Issue: Issue 3 (2016) – Supplement 3

Review Article

Inflammatory demyelinating disease of central nervous system in clinical practice

Joana Guimarães and Carolina Garrett
The diagnosis and treatment of central nervous system (CNS) idiopathic inflammatory demyelinating diseases have been recurrently reviewed over the past two decades. In this group of diseases, Multiple Sclerosis (MS) is the most frequent CNS pathology. However, MS diagnosis requires a systematic exclusion of alternative diagnoses. Our objective with this review is to help standardize and optimize the use of actual diagnosis criteria of inflammatory demyelinating diseases of the CNS, in clinical practice. Its focus is on exclusion of potential MS mimics, differentiating between MS and non-MS idiopathic inflammatory demyelinating conditions, as well as in the diagnosis of common initial isolated clinical syndromes.

Keywords: Multiple sclerosis, Differential diagnosis, Red flags.

Special Issue on Inflammatory Demyelinating Diseases of the Central Nervous System

International Journal of Clinical Neurosciences and Mental Health 2016; 3(Suppl. 3):S02
DOI: http://dx.doi.org/10.21035/ijcnmh.2016.3(Suppl.3).S02
Icon_pdf Download PDF